omega-n-methylarginine has been researched along with thymosin beta(4) in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (thymosin beta(4)) | Trials (thymosin beta(4)) | Recent Studies (post-2010) (thymosin beta(4)) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 784 | 9 | 392 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, JH; Moon, EY; Ryu, YK | 1 |
1 other study(ies) available for omega-n-methylarginine and thymosin beta(4)
| Article | Year |
|---|---|
The actin-sequestering protein thymosin beta-4 is a novel target of hypoxia-inducible nitric oxide and HIF-1α regulation.
Topics: Actins; Cell Movement; Gene Expression Regulation; HeLa Cells; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Promoter Regions, Genetic; Protein Binding; RNA Interference; RNA, Small Interfering; Thymosin | 2014 |